Death or cerebral palsy · preventing bronchopulmonary dysplasia in preterm infants
Early systemic postnatal corticosteroids showed no clear difference in mortality or cerebral palsy at latest reported age compared with placebo or no treatment (high certainty).
1 finding from 1 review
Intervention not reported
Bleeding (early, up to 1 month after treatment) · patients diagnosed with acute DVT
The intervention probably leads to higher bleeding (early, up to 1 month after treatment) (moderate certainty).
1 finding from 1 review
Adverse effects*: leaving the study early ‐ did not leave · patients with schizophrenia
VIDEO GAMES (COMMERCIAL NON‐EXERGAMES) (plus standard care) showed no clear difference in adverse effects*: leaving the study early ‐ did not leave ‐ by end… compared with COGNITIVE REMEDIATION (plus standard care) (low certainty).
1 finding from 1 review
Lost to treatment · people with both severe mental illness and substance misuse
Integrated models of care showed no clear difference in leaving the study early: Lost to treatment compared with standard care (low certainty).
1 finding from 1 review
Lost to treatment · people with both severe mental illness and substance misuse
Cognitive behavioural therapy showed no clear difference in leaving the study early: Lost to treatment compared with standard care (low certainty).
1 finding from 1 review
Lost to treatment · people with both severe mental illness and substance misuse
Contingency management probably leads to higher leaving the study early: Lost to treatment compared with standard care (moderate certainty).
1 finding from 1 review
Lost to treatment · people with both severe mental illness and substance misuse
It is very uncertain whether skills training changes leaving the study early: Lost to treatment compared with standard care (very low certainty).
1 finding from 1 review
Lost to treatment · people with both severe mental illness and substance misuse
Cognitive behavioural therapy + motivational interviewing showed no clear difference in leaving the study early: Lost to treatment compared with standard care (low certainty).
1 finding from 1 review
Leavint the study early: Loss to Treatment · people with both severe mental illness and substance misuse
1 finding from 1 review
Lost to treatment · people with both severe mental illness and substance misuse
1 finding from 1 review
Satisfaction with treatment: leaving the study early Endpoint data (events) · schizophrenia
It is very uncertain whether haloperidol discontinuation changes satisfaction with treatment: leaving the study early compared with haloperidol continuation (very low certainty).
1 finding from 1 review
Satisfaction with treatment: 1. Leaving the study early ‐ long term · people in the prodromal stage of psychosis
Group A: omega‐3 fatty acids showed no clear difference in satisfaction with treatment: leaving the study early Long‐term… compared with placebo (low certainty).
1 finding from 1 review
Satisfaction with treatment: leaving the study early Endpoint data (events) · people in the prodromal stage of psychosis
It is very uncertain whether group B antipsychotic drugs: amisulpiride + needs‐focused intervention changes satisfaction with treatment: leaving the study early Endpoint data… compared with needs‐focused intervention (very low certainty).
1 finding from 1 review
Satisfaction and acceptability of treatment (medium term) ‐ leaving the study early · people in the prodromal stage of psychosis
It is very uncertain whether group B antipsychotic drugs: olanzapine + supportive intervention changes satisfaction with treatment: leaving the study early Endpoint data… compared with placebo + supportive intervention (very low certainty).
1 finding from 1 review
Satisfaction and acceptability of treatment (medium term) ‐ leaving the study early · people in the prodromal stage of psychosis
It is very uncertain whether group B cognitive behavioural therapy: cognitive behavioural therapy… changes satisfaction with treatment: leaving the study early Endpoint data… compared with supportive therapy (very low certainty).
1 finding from 1 review
Satisfaction with treatment: leaving the study early Endpoint data (events) · people in the prodromal stage of psychosis
It is very uncertain whether group B cognitive behavioural therapy: cognitive behavioural therapy… changes satisfaction with treatment: leaving the study early Endpoint data… compared with cognitive behavioural therapy + placebo (very low certainty).
1 finding from 1 review
Satisfaction with treatment: 1. Leaving the study early ‐ long term · people in the prodromal stage of psychosis
It is very uncertain whether group B cognitive behavioural therapy: cognitive behavioural therapy… changes satisfaction with treatment: leaving the study early (events)… compared with needs‐based intervention (very low certainty).
1 finding from 1 review
Satisfaction with treatment: leaving the study early Endpoint data (events) · people in the prodromal stage of psychosis
It is very uncertain whether group C cognitive behavioural therapy: cognitive behavioural therapy… changes satisfaction with treatment: leaving the study early Endpoint data… compared with supportive therapy + placebo (very low certainty).
1 finding from 1 review
Satisfaction with treatment: leaving the study early Endpoint data (events) · people in the prodromal stage of psychosis
It is very uncertain whether group C cognitive behavioural therapy: cognitive behavioural therapy… changes satisfaction with treatment: leaving the study early Endpoint data… compared with non‐directive reflective listening + supportive intervention (very low certainty).
1 finding from 1 review
Satisfaction with treatment: leaving the study early Endpoint data (events) · people in the prodromal stage of psychosis
It is very uncertain whether group A: amino acids changes satisfaction with treatment: leaving the study early Endpoint data… compared with placebo (very low certainty).
1 finding from 1 review